Biotherapeutics Manufacturing Centre

Profile

The Ottawa Hospital's Biotherapeutics Manufacturing Centre(BMC) is a cell and gene therapy CDMO focused on turning promising breakthroughs into clinically proven and commercially viable advanced oncology and rare disease therapies. With two decades of experience, the BMC brings together translational expertise, early phase clinical trial capabilities, direct access to patients, and has become a trusted partner for early-phase clinical trials across North America, Europe, and Asia.

biotherapeutics manufacturing centre

Website

ohri.ca/bmc

Contact


Event details

Date: June 22 - 25, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

23 in total